GlobeImmune Cash Flow - Annual (OTCMKTS:GBIM)

Add to My Stocks
$0.38 $0 (0%) GBIM stock closing price Sep 21, 2018 (Closing)

The financial analysis of GBIM requires an investor to check the cash flows for GlobeImmune. The profit-loss statement shows GlobeImmune profits, the balance sheet shows GlobeImmune debt, and the cash flow statement reflects the liquidity and solvency of a firm. This statement reflects the company's ability to generate cash flows. The cash flow statement is essetial while conducting the GlobeImmune cash flow analysis and can be used to measure the operating performance of GlobeImmune compared to various industry peers like SUWN stock and ACUR stock. GlobeImmune saw a outflow of $- from investing activities for 2015.

View details of GlobeImmune cash flows for latest & last 10 financial years
show more
Fiscal year is Jan - Dec2015201420132012
Net Income Cash Flow
-2.76M-16.26M9.47M-2.01M
Depreciation Depletion Amortization Cash-Flow----
Net Increase (Decrease) in Assets Liabilities-4.54M-4.52M-4.69M-10.39M
Cash From (used in) Discontinued Operations----
Other Adjustments Net-0.01M10.44M-1.62M-1.58M
Net Cash from (used by) Operating Activities
-7.12M-10.05M3.93M-13.06M
Increase (Decrease) in Prop Plant And Equipment--0.16M-0.01M-0.1M
Acquisition Disposition of Subsidiaires----
Increase (Decrease) in Investments----
Other Cash Inflow (Outflow) from Investment Activities----
Net Cash from (used by) Investment Activities
--0.16M-0.01M-0.1M
Issuance (Purchase) of Equity Shares-17.28M--
Issuance (Repayment) of Debt Securities-7.5M--
Increase (Decrease) in Bank & Other Borrowings----
Payment of Dividends & Other Cash Distributions----
Other Cash from (used by) Financing Activities--3.68M--
Net Cash from (used by) Financing Activities
-21.1M--
Effect of Exchange Rate Changes on Cash----
Net Change in Cash & Cash Equivalents
-6.91M10.88M3.92M-13.15M
Cash & Equivalents at Beginning of Year16.81M5.92M2M15.15M
Cash & Equivalents at Year End9.9M16.81M5.92M2M
All figures in USD. M: Millions of USD, B: Billions of USD.

GlobeImmune stock price history provides insight into historical stock price fluctuations, and GlobeImmune stock comparison chart enables peer comparison. Some of the key terms used in the statement of cash flows are:

  • Net Change in Cash and Cash Equivalents: A positive net change in cash and cash equivalents shows that GlobeImmune is able to meet its expenditure and grow cash at hand which demonstrates the financial strength of the company's balance sheet. Also see - GlobeImmune stock price movement.
  • Cash Flow from operating activities: GlobeImmune reported a negative operating cash flow of $-7.12M for 2015 and has seen an increase from the previous year. Operating cash flow comes from main business activities. Investors look for positive cash flow from recurring operating activities.
  • Cash Flow from investment activities: This includes buying/selling of land and equipment, acquisitions and mergers, sell-off, investment in other companies like buying bonds, stocks etc., and was $- for GBIM in last 2015 report.
  • Inflow of cash in the form of bank loans and shareholders equity, and outflow of cash because of dividend payments, share repurchase payments etc. come under financing activities. The cash generated from these activities was $- for GlobeImmune.

Key Financial Ratios For GlobeImmune Cash Flow